Triple-Negative Breast Cancer Panel 2; Mesenchymal & Luminal Morphology (ATCC® TCP-1002™)

Organism: Homo sapiens, human  / 

Permits Notice: Necessary Permits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Organism Homo sapiens, human
Components BT-549, ATCC HTB-122
Hs 578T ATCC HTB-126
MDA-MB-231 ATCC HTB-26
MDA-MB-436 ATCC HTB-130
MDA-MB-157 ATCC HTB-24
MDA-MB-453 ATCC HTB-131
Applications
Biological understanding of top genetic alterations across tumor types
Testing small molecules or biologics for cancer drug development
Validation and characterization of potential cancer driver genes
Functional profiling and molecular profiling of subtype-specific cancer cell lines
Type Strain no
Biosafety Level 1
Comments
A panel of 6 triple-negative breast tumor cell lines sharing a mesenchymal-like or luminal morphology. See J Clinical Inv (2011) 121(7):2750-2767 for more information.
RefLehmann BD, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121: 2750-2767, 2011. PubMed: 21633166
Product Format frozen
Storage Conditions LN vapor (less than -130°C) only
Permits Notice: Necessary Permits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Product Sheet
Product Sheet
Certificate of Analysis
Certificate of Analysis
MSDS
MSDS
Other Documentation
Other Document
Cancer cell line mutation data